Clinical Trial

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-03-07; most recent amendment 2025-06-24.
Status change: Not Yet Recruiting → Recruiting 2024-06-20
Trial Details
NCT Number NCT05775146
Lead Sponsor AHS Cancer Control Alberta
Conditions Colorectal Cancer, Liver Metastasis Colon Cancer
Enrollment 24 participants
Start Date 2024-06-18
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-27